Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout. (2018)
Attributed to:
Renewal of the Network of Hubs for Trials Methodology Research.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.13427
PubMed Identifier: 28888218
Publication URI: http://europepmc.org/abstract/MED/28888218
Type: Journal Article/Review
Volume: 84
Parent Publication: British journal of clinical pharmacology
Issue: 1
ISSN: 0306-5251